Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2016 1
2018 4
2019 2
2020 2
2021 4
2022 3
2023 2
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

19 results

Results by year

Filters applied: . Clear all
Page 1
Metabolomics Signatures of serotonin reuptake inhibitor (Escitalopram), serotonin norepinephrine reuptake inhibitor (Duloxetine) and Cognitive Behavior Therapy on Key Neurotransmitter Pathways in Major Depressive Disorder.
Bhattacharyya S, MahmoudianDehkordi S, Sniatynski MJ, Belenky M, Marur VR, Rush AJ, Craighead WE, Mayberg HS, Dunlop BW, Kristal BS, Kaddurah-Daouk R; Mood Disorder Precision Medicine Consortium. Bhattacharyya S, et al. medRxiv [Preprint]. 2024 Apr 3:2024.04.02.24304677. doi: 10.1101/2024.04.02.24304677. medRxiv. 2024. PMID: 38633777 Free PMC article. Preprint.
Acylcarnitines metabolism in depression: association with diagnostic status, depression severity and symptom profile in the NESDA cohort.
Montanari S, Jansen R, Schranner D, Kastenmüller G, Arnold M, Janiri D, Sani G, Bhattacharyya S, Dehkordi SM, Dunlop BW, Rush AJ, Penninx BWHJ, Kaddurah-Daouk R, Milaneschi Y. Montanari S, et al. medRxiv [Preprint]. 2024 Feb 15:2024.02.14.24302813. doi: 10.1101/2024.02.14.24302813. medRxiv. 2024. PMID: 38405847 Free PMC article. Preprint.
The Metabolome-Wide Signature of Major Depressive Disorder.
Jansen R, Milaneschi Y, Schranner D, Kastenmuller G, Arnold M, Han X, Dunlop BW; Mood Disorder Precision Medicine Consortium; Rush AJ, Kaddurah-Daouk R, Penninx BW. Jansen R, et al. Res Sq [Preprint]. 2023 Sep 21:rs.3.rs-3127544. doi: 10.21203/rs.3.rs-3127544/v1. Res Sq. 2023. PMID: 37790319 Free PMC article. Preprint.
Circulating metabolites modulated by diet are associated with depression.
van der Spek A, Stewart ID, Kühnel B, Pietzner M, Alshehri T, Gauß F, Hysi PG, MahmoudianDehkordi S, Heinken A, Luik AI, Ladwig KH, Kastenmüller G, Menni C, Hertel J, Ikram MA, de Mutsert R, Suhre K, Gieger C, Strauch K, Völzke H, Meitinger T, Mangino M, Flaquer A, Waldenberger M, Peters A, Thiele I, Kaddurah-Daouk R, Dunlop BW, Rosendaal FR, Wareham NJ, Spector TD, Kunze S, Grabe HJ, Mook-Kanamori DO, Langenberg C, van Duijn CM, Amin N. van der Spek A, et al. Mol Psychiatry. 2023 Sep;28(9):3874-3887. doi: 10.1038/s41380-023-02180-2. Epub 2023 Jul 26. Mol Psychiatry. 2023. PMID: 37495887 Free PMC article.
Network science approach elucidates integrative genomic-metabolomic signature of antidepressant response and lifetime history of attempted suicide in adults with major depressive disorder.
Grant CW, Wilton AR, Kaddurah-Daouk R, Skime M, Biernacka J, Mayes T, Carmody T, Wang L, Lazaridis K, Weinshilboum R, Bobo WV, Trivedi MH, Croarkin PE, Athreya AP. Grant CW, et al. Front Pharmacol. 2022 Oct 3;13:984383. doi: 10.3389/fphar.2022.984383. eCollection 2022. Front Pharmacol. 2022. PMID: 36263124 Free PMC article.
Metabolomic and inflammatory signatures of symptom dimensions in major depression.
Brydges CR, Bhattacharyya S, Dehkordi SM, Milaneschi Y, Penninx B, Jansen R, Kristal BS, Han X, Arnold M, Kastenmüller G, Bekhbat M, Mayberg HS, Craighead WE, Rush AJ, Fiehn O, Dunlop BW, Kaddurah-Daouk R; Mood Disorders Precision Medicine Consortium. Brydges CR, et al. Brain Behav Immun. 2022 May;102:42-52. doi: 10.1016/j.bbi.2022.02.003. Epub 2022 Feb 4. Brain Behav Immun. 2022. PMID: 35131442 Free PMC article.
Multi-omics driven predictions of response to acute phase combination antidepressant therapy: a machine learning approach with cross-trial replication.
Joyce JB, Grant CW, Liu D, MahmoudianDehkordi S, Kaddurah-Daouk R, Skime M, Biernacka J, Frye MA, Mayes T, Carmody T, Croarkin PE, Wang L, Weinshilboum R, Bobo WV, Trivedi MH, Athreya AP. Joyce JB, et al. Transl Psychiatry. 2021 Oct 7;11(1):513. doi: 10.1038/s41398-021-01632-z. Transl Psychiatry. 2021. PMID: 34620827 Free PMC article.
19 results